Hims & Hers Health (HIMS) Q1 swung to a loss of $0.40 per diluted share late Monday, from an earnings of $0.20 a year ago.
Analysts polled by FactSet expected EPS of $0.03.
Revenue for the three months ended March 31 rose to $608.1 million from $586.0 million a year earlier.
Analysts surveyed by FactSet expected $616.8 million.
The company expects Q2 revenue of $680 million to $700 million. Analysts expect $643.0 million.
The firm expects 2026 revenue of $2.8 billion to $3.0 billion, up from $2.7 billion to $2.9 billion. Analysts expect $2.75 billion.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.